In autoimmune myasthenia gravis (MG), the identification of antibodies and characterization
of serological subgroups is of great importance for diagnosis and management of the …

Objective This study aimed to summarize the clinical characteristics and prognosis of
patients with anti-acetylcholine receptor (AChR) positive myasthenia gravis (MG) with a …

Background and purpose Myasthenia gravis (MG) is an autoimmune disease caused by
antibody mediated impairment in the neuromuscular junction. Seronegative MG (SNMG) …

Myasthenia gravis (MG) is caused by the failure of neuromuscular transmission mediated by
pathogenic autoantibodies (Abs). Generally, patients with MG are divided into 3 groups:(1) …

Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and
fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by …

Myasthenia gravis (MG) is the most common immune-mediated disorder of the
neuromuscular junction. Anti-acetylcholine receptor (anti-AChR), anti-muscle-specific kinase …

Background: Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular
junction in which a clinical diagnosis may be confirmed with serological testing. The most …

Introduction Our aim in this study was to identify the prevalence and clinical characteristics of
LRP4/agrin‐antibody–positive double‐seronegative myasthenia gravis (DNMG). Methods …

Background Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients
have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while …

Myasthenia gravis (MG) is an autoimmune disorder characterized by a defect in synaptic
transmission at the neuromuscular junction causing fluctuating muscle weakness with a …